• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    The Next Steps for Recovery and Rehab

    Scratching the Surface: A Roundtable on Coatings and Treatments

    Influencers on the Orthopedic Implant Manufacturing Market

    Innovation Iteration: Latest Advancements in Design & Prototyping

    Robot Recharge: Orthopedic Surgical Robotics Update
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    ODT's Most-Read Stories This Week—June 25

    3Spine Inc. Receives IDE Approval for U.S. Pivotal Clinical Trial

    Volume-Based Procurement to Reduce Chinese Orthopedic Market Value

    Isto Biologics Rolls Out Influx Fibrant

    Bioventus Amends CartiHeal Acquisition Structure
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    ODT's Most-Read Stories This Week—June 25

    Isto Biologics Rolls Out Influx Fibrant

    Bioventus Amends CartiHeal Acquisition Structure

    Medtronic's LigaPASS 2.0 OK'ed for Ligament Augmentation in Spine Surgery

    Theradaptive Gains 3rd Breakthrough Designation for Spinal Fusion
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Giving Knee Replacement Surgery a Much-Needed Update

    It’s All About the Data for Supply Chain and Inventory Management

    Minimizing Risks in Minimally Invasive Surgery

    Giving Athletes Their Lives Back with Better Knee Braces

    ODT Forum '22 is Another Successful Orthopedic Tech Conference
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Braxton Manufacturing

    Modern Plastics

    AV&R

    Life Science Outsourcing Inc.

    Tiodize
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Editorial

    CMS Changes Create Uncertainty for ASCs, Orthopedics, and Patients

    The flip-flop by CMS on the elimination of the Inpatient Only list has created questions regarding what procedures will be available where.

    CMS Changes Create Uncertainty for ASCs, Orthopedics, and Patients
    Sean Fenske, Editor-in-Chief09.14.21
    During President Trump’s term, an executive order (EO)—Protecting and Improving Medicare for Our Nation’s Seniors—was issued (EO 13890 on Oct. 3, 2019) with the intention to improve access to healthcare services. As part of that order, it was announced the Centers for Medicare & Medicaid Services (CMS) would eliminate its Inpatient Only (IPO) list, which contained approximately 1,700 procedures. These procedures were only paid for by Medicare when performed in the hospital as inpatient.

    Starting with the elimination of almost 300 primarily musculoskeletal-related services at the start of 2021, the list would be completely eliminated by 2024. This would enable the growing ASC (ambulatory surgical center) community (among other options) to offer services previously exclusive to hospitals. The intent was to encourage competition among healthcare providers, enabling options for patients.

    Unfortunately, not everyone was in agreement with the move. In its CY 2022 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Proposed Rule (CMS-1753-P), CMS stated it had “received a large number of stakeholder comments throughout the CY 2021 rulemaking cycle and following issuance of the final rule with comment period that opposed the elimination of the IPO list primarily due to patient safety concerns, stating that the IPO list serves as an important programmatic safeguard.”

    As a result, CMS stated it would restore the 298 previously removed services to the IPO list at the start of CY 2022. According to the agency, “This change in policy would ensure that any service removed from the IPO list has been reviewed against Medicare’s longstanding IPO list criteria to determine if it is appropriate for Medicare to pay for the provision of the service in the outpatient setting. Furthermore, CMS is proposing to codify the longstanding criteria for removal of procedures from the IPO list to make clear in regulatory text how we will evaluate future procedures for removal.”

    In the same announcement, CMS indicated it was reinstating the criteria (based on patient safety) used to determine additions to the ASC Covered Procedure List (CPL). As a result of the action, 258 of the 267 procedures added to the list in CY 2021 would be removed. The agency is welcoming comments on the 258 procedures.

    CMS also announced, in connection with the move, it would implement a program in which anyone could nominate a procedure to be considered for addition to the ASC CPL. If the nominee was accepted, the procedure would be added to the list during the next rulemaking schedule.

    In the short term, any company that sells an orthopedic device used in a procedure removed from the ASC CPL should seriously consider the nomination option (once available). Of course, patient safety should be paramount, but with such a large move, it’s certainly possible some procedures are inherently safe to be performed in an ASC setting. It’s also quite possible these procedures are missed or not given priority for review should no one nominate them. You know, squeaky wheel…

    In the big picture, this was a completely botched move. This isn’t a matter of enabling a handful of procedures to be performed outside the hospital setting only to be returned to that status a year later. This type of uncertainty is bad for device makers, bad for healthcare professionals, and, most notably, bad for patients.

    I’m fully supportive of putting patient safety first. When it comes to healthcare, that must always be the number one priority. So I don’t have an issue with the move specifically; I have more of a problem with a system that allowed it to happen. Executive order or not, healthcare cannot change on the whim of whomever is in power at the time. It needs to be well considered, well planned, and well executed. Unfortunately, political timelines and healthcare timelines don’t always align. Thus, we have “unhealthy” execution of plans, such as this one.

    If you’re a company with products “in limbo” between potentially new customers (e.g., ASCs) and more established ones (e.g., hospitals), I would be sure to be active during any CMS comment period. Further, encourage doctors, surgeons, and even patients who are benefiting and/or using your product to comment as well. Again, I’m not advocating circumventing patient safety, but I think it’s safe to assume not all 258 procedures should have been removed from the ASC CPL (just as it is likely not all 258 procedures should have been added to it in the first place).

    Hopefully, the right people will ultimately make the best decisions based on what’s best for patients, and not what’s best for device makers, surgeons, or politicians. 

    Sean Fenske, Editor-in-Chief
    sfenske@rodmanmedia.com
    Loading, Please Wait..

    Trending
    • Professor Reinhold Ganz Is First Recipient Of Dominik C. Meyer Award
    • Bioventus Launches DUROLANE In The U.S.
    • Molybdenum-Rhenium Biomaterial: Something ‘MoRe’?
    • Former Zimmer Biomet CEO David Dvorak Named Chairman Of THINK Surgical
    • Mini MRI For Hand And Wrist Imaging Can Be Used Nearly Anywhere
    Breaking News
    • ODT's Most-Read Stories This Week—June 25
    • 3Spine Inc. Receives IDE Approval for U.S. Pivotal Clinical Trial
    • Volume-Based Procurement to Reduce Chinese Orthopedic Market Value
    • Isto Biologics Rolls Out Influx Fibrant
    • Bioventus Amends CartiHeal Acquisition Structure
    View Breaking News >
    CURRENT ISSUE

    May/June 2022

    • The Next Steps for Recovery and Rehab
    • Scratching the Surface: A Roundtable on Coatings and Treatments
    • Influencers on the Orthopedic Implant Manufacturing Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Florida Food Products Acquires Javo
    Roquette Launches Nutralys Rice Protein
    New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy
    Coatings World

    Latest Breaking News From Coatings World

    The Southern Society for Coatings Technology's 84th Annual Technical Conference A Success
    PPG to Showcase Specialty Automotive, Aerospace Adhesives, Sealants at Adhesives & Bonding Expo
    PPG’s New Paint for a New Start Initiative to Transform 25-plus Schools Worldwide
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most Read Stories This Week—June 25
    Magnetic Insight Announces $17 Million in Series B Funding
    BreatheSuite Adds Brad Fluegel to its Board
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pierre Fabre and Lonza Enter Manufacturing Agreement
    MasterControl and Elemental Machines Form Biomanufacturing Partnership
    Qosina Strengthens Aseptic Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Benefit Exec Joins Madison Reed's Board
    Peroni & Ellis Brooklyn Launch Fragrance Collection Inspired by Italian Spritz Cocktails
    Rhode Is Trending for June, Trendalytics Says
    Happi

    Latest Breaking News From Happi

    Spate’s Nose for the Latest Beauty Trends Says The Skunk Stripe, Collagen Serum and Waterproof Eyeshadow are Top of Mind for Consumers this Summer
    A Suitor Emerges for Revlon, SK Capital’s New Dealmaker & P&G’s Indoor Air Quality Efforts
    Wonder Curl Wins GlossWire's GlossPitch Competition
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: INX’s VC Fund, Screen Industry and Ball Top This Week’s News
    British Coatings Federation Posts Online History
    Orion Announces Price Increases, Reduced Payment Terms
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PCMC teams with IGT, Fujifilm makes big announcement and more
    Loftware recognized as 'AIDC Company of the Year'
    Schreiner MediPharm highlights sustainability of Needle-Trap technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: SWM and Neenah Introduce Mativ Inc., Avgol honored for Biotransformation Technology & More
    Tranzonic Names VP of Supply Chain
    Ontex Climate Action Targets Approved by Science-Based Targets Initiative
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—June 25
    3Spine Inc. Receives IDE Approval for U.S. Pivotal Clinical Trial
    Volume-Based Procurement to Reduce Chinese Orthopedic Market Value
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: eMagin, Applied Materials, and Schott Top This Week’s Stories
    NREL Names Jennifer Logan to Leadership Team as CFO
    National Grid Renewables Orders 2 GW of First Solar Modules

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login